Ado-trastuzumab Emtansine (Kadcyla®)

OncoLink Team
Ultima Vez Modificado: 20 de julio del 2015

Translation for this article does not exist


Click on any of these terms for more related articles


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

FDA Approves Kadcyla for Late-Stage Breast Cancer

Feb 25, 2013

Fourth drug approved targeting HER2 protein; slows disease progression, prolongs survival

ASCO: T-DM1 Ups Progression-Free Survival in Breast Cancer

Jun 5, 2012

T-DM1 is a well-tolerated, novel therapy for HER2+ advanced breast cancer patients

Chemo, Trastuzumab, Surgery Up Survival in HER2-Positive MBC

Jul 19, 2011

After adjustment, only chemo, trastuzumab linked to survival for patients with CNS metastases